Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Finasteride effectively treats male pattern baldness.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

Gamma-ray exposure improves genome editing efficiency in mice using the i-GONAD method.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Combination drug therapy improves hair growth and patient care for androgenetic alopecia.

Detachable microneedles with chitin derivatives effectively promote hair regrowth in androgenic alopecia without toxicity.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Setipiprant did not significantly improve hair growth in men with hair loss.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Adenosine lotion improves hair thickness and density in women with thinning hair.

The compound was successfully made and shows potential for treating prostate cancer.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

Low-dose oral minoxidil is effective and safe for treating hair loss in men and women.